The kids are alright — on GLP-1s, that is. A new study found that the blockbuster treatment Mounjaro can dramatically lower blood sugar and body weight in children as young as 10 with Type 2 diabetes.
Hosted on MSN
Corcept Therapeutics’ Korlym Shows Glucose Control, Weight Reduction in Hypercortisolism, Type 2 Diabetes Patients
Corcept Therapeutics Incorporated (NASDAQ:CORT) is one of the best NASDAQ growth stocks to buy for the next 3 years. On June 24, Corcept Therapeutics announced positive results from the CATALYST trial ...
Hosted on MSN
Neurosurgeon with 33 years of experience shares 3 rules to control body weight: ‘For 21 days…’
When trying to manage your body weight, your primary focus typically centres on adjusting your diet to support fat loss and incorporating regular gym workouts. However, it is also important to train ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback